Pell Bio-Med Technology Co., Ltd. (6949)
TWSE
46.70
-0.15 (-0.32%)
Closed
Oct 12, 2026
Day's Range
45.3047.50
52 wk Range
44.351,490.00
Financial Statements - 6949 - Pell Bio-Med Technology Co., Ltd.
Revenue
31.42M▲ 60.1%
Net Income
-452.67M▼ 14.6%Net Margin -1440.5%
EBITDA
-403.50M▼ 16.6%
Free Cash Flow
-508.89M▲ 2.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Sales | 31.42M | 19.63M | 18.03M | 17.15M | 13.97M |
| Cost of Goods | 35.81M | 31.95M | 44.17M | 28.41M | 18.34M |
| Gross Profit | -4.39M | -12.32M | -26.14M | -11.25M | -4.37M |
 Operating Expense | - | - | - | - | - |
| Operating Income | -467.35M | -413.49M | -411.24M | -236.04M | -195.96M |
| Non-Operating Interest | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - |
| Pre Tax Income | -452.67M | -395.11M | -401.23M | -231.27M | -188.95M |
| Income Tax | 0 | 0 | 2K | 0 | 0 |
| Net Income | -452.67M | -395.11M | -401.24M | -231.27M | -188.95M |
| EPS Basic | -7.23 | -6.772063 | -8.62 | -5.87 | -5.68 |
| EPS Diluted | -7.23 | -6.772063 | -8.62 | -5.87 | -5.68 |
| Basic Shares Outstanding | 58.63M | 57.54M | 46.25M | 39.20M | 33.26M |
| Diluted Shares Outstanding | 58.63M | 57.54M | 46.25M | 39.20M | 33.26M |
| Ebit | -450.62M | -392.85M | -398.68M | -229.91M | -187.44M |
| Ebitda | -403.50M | -345.97M | -353.06M | -198.80M | -157.28M |
| Net Income Continuous Operations | -452.67M | -395.11M | -401.23M | -231.27M | -188.95M |
| Minority Interests | 28.73M | 5.70M | 2.48M | 1.14M | 0 |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
